Is agilon health (AGL) Undervalued After Revenue Growth And Value Based Care Gains?

Simply Wall St.10-17

Recent commentary around agilon health (AGL) has focused on its annual revenue and earnings growth, as well as its efforts to move primary care physicians into value-based Medicare models that rely on...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2676543183?lang=en_US&edition=fundamental","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6032000-choice2-card/1788952998790","is_english":true,"pubTime":"2026-10-17 10:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2676543183","market":"nz","top_or_hot":-1,"title":"Is agilon health (AGL) Undervalued After Revenue Growth And Value Based Care Gains?","media":"Simply Wall St.","content":"<div>\n<p>Recent commentary around agilon health (AGL) has focused on its annual revenue and earnings growth, as well as its efforts to move primary care physicians into value-based Medicare models that rely on...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-agl/agilon-health/news/is-agilon-health-agl-undervalued-after-revenue-growth-and-va\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is agilon health (AGL) Undervalued After Revenue Growth And Value Based Care Gains?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs agilon health (AGL) Undervalued After Revenue Growth And Value Based Care Gains?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-10-17 10:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nyse-agl/agilon-health/news/is-agilon-health-agl-undervalued-after-revenue-growth-and-va><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Recent commentary around agilon health (AGL) has focused on its annual revenue and earnings growth, as well as its efforts to move primary care physicians into value-based Medicare models that rely on...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-agl/agilon-health/news/is-agilon-health-agl-undervalued-after-revenue-growth-and-va\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AGL.AU","symbol_name":"AGL ENERGY LTD","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-agl/agilon-health/news/is-agilon-health-agl-undervalued-after-revenue-growth-and-va","article_id":"2676543183","we_media_id":null,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6032000-choice2-card/1788952998790"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-agl/agilon-health/news/is-agilon-health-agl-undervalued-after-revenue-growth-and-va","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2676543183","pubTimestamp":1792204426,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Recent commentary around agilon health (AGL) has focused on its annual revenue and earnings growth, as well as its efforts to move primary care physicians into value-based Medicare models that rely on long-term partnership structures.\nRecent share price action for agilon health has been choppy, with the stock down 3.76% on a 1-day share price basis and 5.06% over 30 days, yet still posting a very large year-to-date share price gain of 405.46% that aligns with a 254.70% 1-year total...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"AGL.AU":"AGL ENERGY LTD","AGL":"agilon health, inc."},"translate_title":"在收入增长和基于价值的护理收益之后，agilon health (AGL) 是否被低估了？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AGL":1.5,"AGL.AU":1.5},"content_text":"Recent commentary around agilon health (AGL) has focused on its annual revenue and earnings growth, as well as its efforts to move primary care physicians into value-based Medicare models that rely on long-term partnership structures. Recent share price action for agilon health has been choppy, with the stock down 3.76% on a 1-day share price basis and 5.06% over 30 days, yet still posting a very large year-to-date share price gain of 405.46% that aligns with a 254.70% 1-year total shareholder return. That rally contrasts with a 34.44% decline over 90 days and deep 3-year and 5-year total shareholder return declines of 82.39% and 85.64%. This suggests that recent enthusiasm around the value-based care model and reported revenue and earnings growth is rebuilding momentum after a difficult longer-term run. Scan other value-based care and quality-focused opportunities by reviewing the hand picked list of solid balance sheet and fundamentals (25 results) that align with the kind of fundamentals investors are watching at agilon health. agilon health has swung from deep multi year losses to a very large year to date surge. Is that move really tracking the underlying Medicare platform, or mostly a reset in sentiment that the current share price now needs to justify through valuation? AdvertisementMost Popular Narrative: 28% Undervalued The most followed narrative on agilon health puts fair value around $118.33 per share, versus a last close of $85.12. The gap investors are debating is substantial and rooted in the Medicare platform story rather than short term price swings.  Expansion of clinical pathways, successful scaling of chronic disease management programs, and strong PCP and patient retention reinforce agilon health's operational leverage, supporting expectations for durable earnings growth, enhanced gross margin, and improved operating cash flow as the platform scales.  See why 10 investors see agilon health as 28% undervalued. Result: Fair Value of $118.33 (UNDERVALUED) Still, concentration in a few payer relationships and recent leadership turnover at agilon health could quickly challenge the 28% undervalued narrative if renegotiations or execution slip. Find out about the key risks to this agilon health narrative. Next Steps Mixed sentiment around agilon health is clear, with investors weighing both enthusiasm and concern. Move quickly to review the underlying data and shape your own view using the 3 key rewards and 1 important warning sign. Looking for more ideas beyond agilon health? If you stop your research with agilon health, you risk missing other compelling setups that could better match your risk tolerance and return goals.  Target potential mispricing by reviewing the 33 high quality undervalued stocks that combine solid fundamentals with what may be attractive entry points. Prioritise resilience and capital protection by scanning the 32 resilient stocks with low risk scores that focus on steadier balance sheets and lower risk profiles. Get ahead of the crowd by checking the 20 high quality undiscovered gems before attention and liquidity possibly shift their way.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2676543183","isCrawlerRequest":true}